Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hodgkin's lymphoma: evolving concepts with implications for practice.

Ralph M Meyer1, Richard F Ambinder, Sigrid Stroobants

  • 1Juravinski Cancer Centre and McMaster University, Hamilton ONT, Canada.

Hematology. American Society of Hematology. Education Program
|November 25, 2004
PubMed
Summary

Epstein-Barr virus (EBV) may play a role in Hodgkin

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Somatostatin receptor PET response assessment framework for patients with neuroendocrine tumours (V1.0): a modified Delphi consensus from the European Neuroendocrine Tumor Society (endorsed by EANM and NANETS).

The Lancet. Oncology·2026
Same author

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

EBV infection outcomes determined by monocyte and TREG-driven immune dynamics in an ex vivo pbmc model.

PLoS pathogens·2026
Same author

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.

Blood neoplasia·2026
Same author

A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma.

Blood·2026
Same author

The Biology and Clinical Utility of EBV Monitoring in Blood.

Current topics in microbiology and immunology·2026

Area of Science:

  • Oncology
  • Virology
  • Medical Imaging

Background:

  • Hodgkin's lymphoma is a B-cell neoplasm with evolving understandings of its pathogenesis.
  • The role of Epstein-Barr virus (EBV) in Hodgkin's lymphoma pathogenesis is being investigated.
  • Advanced imaging techniques like PET scanning offer new possibilities for lymphoma management.

Purpose of the Study:

  • To review the implications of Epstein-Barr virus (EBV) in Hodgkin's lymphoma.
  • To describe the role of positron emission tomographic (PET) scanning in lymphoma staging and response assessment.
  • To discuss current management strategies for limited-stage Hodgkin's lymphoma and associated toxicities.

Main Methods:

  • Review of literature on EBV and Hodgkin's lymphoma.
  • Analysis of PET scanning's utility in lymphoma staging, response assessment, and residual mass differentiation.
  • Evaluation of treatment outcomes for limited-stage Hodgkin's lymphoma, comparing combined modality therapy with chemotherapy alone.

Main Results:

  • EBV may contribute to Hodgkin's lymphoma tumorigenesis through genetic instability and apoptosis alteration.
  • PET scanning shows promise in lymphoma management, particularly in differentiating residual disease, with high negative predictive values.
  • Combined-modality therapy for limited-stage Hodgkin's lymphoma involves chemotherapy and radiation, but carries risks of late toxicities.

Conclusions:

  • EBV presents potential targets for novel anti-cancer therapies.
  • Further prospective trials are needed to establish PET scanning's clinical utility in routine lymphoma care.
  • Chemotherapy alone may be an alternative to combined modality therapy for limited-stage Hodgkin's lymphoma, balancing disease control with reduced long-term toxicity.

Related Experiment Videos